WASHINGTON, July 1, 2025 /PRNewswire/ -- Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic ...

For the first time, people with bronchiectasis will have a treatment option. The U.S. Food and Drug Administration has approved Insmed's daily pill brensocatib, which will be sold under the brand name ...

Miami (July 31, 2025) – The Bronchiectasis and NTM Association joins other global patient advocacy organizations, professional societies, and lung health experts for the third annual World NTM ...

The American Cancer Society has just updated their lung cancer screening guidelines in an effort to increase earlier detection. It expands the recommendation of yearly screening via low-dose CT scan ...

Insmed has received approval from the EC for Brinsupri to treat NCFB in patients aged 12 and above with two or more ...

Bronchiectasis is a long-term lung condition where the airways stay widened and inflamed. These airway changes make it harder to breathe and clear mucus. People with bronchiectasis live with a ...

Small cell lung cancer (SCLC) may increase the risk of pneumonia due to a weakened immune system or structural changes to the lungs. SCLC is one of the two main types of lung cancer. Pneumonia is an ...

It was fall 2021, and Aurora Lucas had a stubborn cough and chest pain. However, her doctors dismissed the symptoms, telling her to drink hot water and honey. After three months of hospital visits, ...

A lung cancer diagnosis can feel frightening. And when a family member is diagnosed, you might wonder about your own risk, prompting you to ask if lung cancer is hereditary. Smoking tobacco accounts ...